Abstract

Objective: Auditory verbal hallucinations (AVH), with unclear mechanisms, cause extreme distresses to schizophrenia patients. Deficits of inhibitory top-down control may be linked to AVH. Therefore, in this study, we focused on inhibitory top-down control in schizophrenia patients with AVH.Method: The present study recruited 40 schizophrenia patients, including 20 AVH patients and 20 non-AVH patients, and 23 healthy controls. We employed event-related potentials to investigate the N2 and P3 amplitude and latency differences among these participants during a Go/NoGo task.Results: Relative to healthy controls, the two patient groups observed longer reaction time (RT) and reduced accuracy. The two patient groups had smaller NoGo P3 amplitude than the healthy controls, and the AVH patients showed smaller NoGo P3 amplitude than the non-AVH patients. In all the groups, the parietal area showed smaller NoGo P3 than frontal and central areas. However, no significant difference was found in N2 and Go P3 amplitude between the three groups.Conclusions: AVH patients might have worse inhibitory top-down control, which might be involved in the occurrence of AVH. Hopefully, our results could enhance understanding of the pathology of AVH.

Highlights

  • Auditory verbal hallucinations (AVH) are vivid perceptions of sound that occur without corresponding external stimuli and have a strong sense of reality

  • Studies have been conducted to investigate the efficacy of antipsychotic medications for AVH in schizophrenia patients, which exhibited a significant treatment effect of Inhibitory Top-Down Control in AVH

  • The main effect of trial category revealed that all the participants made more accurate responses in the Go trials than in the NoGo trials (F = 5.493, p = 0.022)

Read more

Summary

Introduction

Auditory verbal hallucinations (AVH) are vivid perceptions of sound that occur without corresponding external stimuli and have a strong sense of reality. It occurs in 60–80% of schizophrenia patients [1] and causes multiple dysfunctions and poor control of behaviors [2, 3]. Studies have been conducted to investigate the efficacy of antipsychotic medications for AVH in schizophrenia patients, which exhibited a significant treatment effect of Inhibitory Top-Down Control in AVH several typical and atypical antipsychotics [8, 9]. Cognitivebehavioral therapy, which is considered as the most investigated psychological intervention of AVH, has an average effect size of 0.44 [12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call